š”š²šš š¦ššŗšŗš®šæš
⢠Zydus Lifesciences and Lupin have signed a licensing and supply agreement to market Zydus' novel drug Saroglitazar Mg for the treatment of Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steato Hepatitis in India.
⢠Under the agreement, Lupin will have semi-exclusive rights to co-market the product under the brand name LINVAS.
⢠Zydus has been expanding access to its novel therapies through licensing agreements with other pharmaceutical companies.